Personalized Nutrition by Prediction of Glycemic Responses.

PubWeight™: 5.05‹?› | Rank: Top 1%

🔗 View Article (PMID 26590418)

Published in Cell on November 19, 2015

Authors

David Zeevi1, Tal Korem1, Niv Zmora2, David Israeli3, Daphna Rothschild1, Adina Weinberger1, Orly Ben-Yacov1, Dar Lador1, Tali Avnit-Sagi1, Maya Lotan-Pompan1, Jotham Suez4, Jemal Ali Mahdi4, Elad Matot1, Gal Malka1, Noa Kosower1, Michal Rein1, Gili Zilberman-Schapira4, Lenka Dohnalová4, Meirav Pevsner-Fischer4, Rony Bikovsky1, Zamir Halpern5, Eran Elinav6, Eran Segal7

Author Affiliations

1: Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
2: Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel; Internal Medicine Department, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel; Research Center for Digestive Tract and Liver Diseases, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel.
3: Day Care Unit and the Laboratory of Imaging and Brain Stimulation, Kfar Shaul Hospital, Jerusalem Center for Mental Health, Jerusalem 9106000, Israel.
4: Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel.
5: Research Center for Digestive Tract and Liver Diseases, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6423906, Israel; Digestive Center, Tel Aviv Sourasky Medical Center, Tel Aviv 6423906, Israel.
6: Immunology Department, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: eran.elinav@weizmann.ac.il.
7: Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot 7610001, Israel; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: eran.segal@weizmann.ac.il.

Associated clinical trials:

Observational Study of Blood Glucose Levels and Gut Microbiota in Healthy Individuals | NCT01892956

Providing Personally Tailored Dietary Suggestions Using Individual Microbiome and Glycemic Index Response. | NCT02945514

Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis? | NCT03009565

Treating Type 2 Diabetes by Reducing Postprandial Glucose Elevations: A Paradigm Shift in Lifestyle Modification | NCT03196895

Benefits of Continuous Glucose Monitoring With GEM Lifestyle Modification for Adults With Type 2 Diabetes | NCT03207893

Strategies To OPpose Sugars With Non-nutritive Sweeteners Or Water (STOP Sugars NOW) Trial | NCT03543644

Glucose, Brain and Microbiota (IRONMEt+CGM) | NCT03889132

The Breast Cancer Personalized Nutrition Study (BREACPNT) | NCT04079270

Personalizing Self-management in Diabetes - Pilot Study | NCT04757233

Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly (SmartAge) | NCT04841668

Optimal Metabolic Health Through Continuous Glucose Monitoring (CGM) | NCT04920058

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform | NCT05121844

Articles citing this

Prior Dietary Practices and Connections to a Human Gut Microbial Metacommunity Alter Responses to Diet Interventions. Cell Host Microbe (2016) 1.43

Chromatin variation associated with liver metabolism is mediated by transposable elements. Epigenetics Chromatin (2016) 1.38

Diet-microbiota interactions as moderators of human metabolism. Nature (2016) 1.31

Microbiome and the future for food and nutrient security. Microb Biotechnol (2017) 1.16

Estimating the reliability of glycemic index values and potential sources of methodological and biological variability. Am J Clin Nutr (2016) 1.10

Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med (2016) 1.05

Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome. MBio (2016) 0.97

Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med (2016) 0.96

The healthy human microbiome. Genome Med (2016) 0.95

Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med (2016) 0.94

Microbiome-wide association studies link dynamic microbial consortia to disease. Nature (2016) 0.93

How gut microbes talk to organs: The role of endocrine and nervous routes. Mol Metab (2016) 0.91

Gut Microbiota: Modulation of Host Physiology in Obesity. Physiology (Bethesda) (2016) 0.90

Interdependence of nutrient metabolism and the circadian clock system: Importance for metabolic health. Mol Metab (2016) 0.87

Signaling in Host-Associated Microbial Communities. Cell (2016) 0.86

Gender-related Differences in Food Craving and Obesity. Yale J Biol Med (2016) 0.83

Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals. Mol Metab (2016) 0.82

The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun (2017) 0.82

Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes. J Mol Med (Berl) (2016) 0.82

Inflammasomes and intestinal inflammation. Mucosal Immunol (2017) 0.81

Internal states drive nutrient homeostasis by modulating exploration-exploitation trade-off. Elife (2016) 0.81

Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiol Rev (2017) 0.80

Machine Learning and Data Mining Methods in Diabetes Research. Comput Struct Biotechnol J (2017) 0.80

Dysbiosis and the immune system. Nat Rev Immunol (2017) 0.79

Macronutrient Composition or Social Determinants? Impact on Infant Outcomes With Gestational Diabetes Mellitus. Diabetes Spectr (2016) 0.79

Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health (2016) 0.79

Biomarkers in Search of Precision Medicine in IBD. Am J Gastroenterol (2016) 0.79

Linking the Microbiota, Chronic Disease, and the Immune System. Trends Endocrinol Metab (2016) 0.79

Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk. Curr Diab Rep (2016) 0.78

Personalized nutrition by prediction of glycaemic responses: fact or fantasy? Eur J Clin Nutr (2016) 0.78

Human gut microbiota and healthy aging: Recent developments and future prospective. Nutr Healthy Aging (2016) 0.78

Toward a Personalized Approach in Prebiotics Research. Nutrients (2017) 0.78

A healthy gastrointestinal microbiome is dependent on dietary diversity. Mol Metab (2016) 0.78

Metabolomics: A Primer. Trends Biochem Sci (2017) 0.77

Gut Microbiota in Cardiovascular Health and Disease. Circ Res (2017) 0.77

Caloric restriction preserves memory and reduces anxiety of aging mice with early enhancement of neurovascular functions. Aging (Albany NY) (2016) 0.77

Smartphone-Based Psychotherapeutic Micro-Interventions to Improve Mood in a Real-World Setting. Front Psychol (2016) 0.77

Regulating inflammation with microbial metabolites. Nat Med (2016) 0.77

Obesity and Asthma: Microbiome-Metabolome Interactions. Am J Respir Cell Mol Biol (2016) 0.77

Multi-omics approaches to disease. Genome Biol (2017) 0.76

Chemical transformation of xenobiotics by the human gut microbiota. Science (2017) 0.76

Mirror, mirror on the wall: which microbiomes will help heal them all? BMC Med (2016) 0.76

The effect of communicating the genetic risk of cardiometabolic disorders on motivation and actual engagement in preventative lifestyle modification and clinical outcome: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr (2016) 0.76

Can Your Microbiome Tell You What to Eat? Cell Metab (2015) 0.76

Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access (2016) 0.76

The Gut Microbiome and Its Role in Obesity. Nutr Today (2016) 0.76

Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction. J Cardiovasc Transl Res (2017) 0.76

The microbial-mammalian metabolic axis: a critical symbiotic relationship. Curr Opin Clin Nutr Metab Care (2016) 0.75

Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes (2017) 0.75

The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial. Trials (2017) 0.75

Nutrition: Glycaemic response variation suggests value of personalized diets. Nat Rev Endocrinol (2015) 0.75

Getting Personal About Nutrition. Trends Mol Med (2016) 0.75

The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol (2017) 0.75

Integrative Therapies in Anxiety Treatment with Special Emphasis on the Gut Microbiome. Yale J Biol Med (2016) 0.75

Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat Rev Nephrol (2017) 0.75

Personalized glucose forecasting for type 2 diabetes using data assimilation. PLoS Comput Biol (2017) 0.75

Nutritional Psychiatry: Where to Next? EBioMedicine (2017) 0.75

Sugar addiction: the state of the science. Eur J Nutr (2016) 0.75

Microbiome: Microbiota-based nutrition plans. Nat Rev Microbiol (2015) 0.75

A systems approach to personalised nutrition: Report on the Keystone Symposium "Human Nutrition, Environment and Health". Appl Transl Genom (2016) 0.75

Siri, What Should I Eat? Cell (2015) 0.75

Blood Glucose Levels of Subelite Athletes During 6 Days of Free Living. J Diabetes Sci Technol (2016) 0.75

Painting a new picture of personalised medicine for diabetes. Diabetologia (2017) 0.75

Nutrition: A personal forecast. Nature (2015) 0.75

Is the way we're dieting wrong? Genome Med (2016) 0.75

Use of Metatranscriptomics in Microbiome Research. Bioinform Biol Insights (2016) 0.75

An Examination of Diet for the Maintenance of Remission in Inflammatory Bowel Disease. Nutrients (2017) 0.75

Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD. PLoS One (2017) 0.75

Phytochemical Pharmacokinetics and Bioactivity of Oat and Barley Flour: A Randomized Crossover Trial. Nutrients (2016) 0.75

Personalized nutrition through big data. Nat Biotechnol (2016) 0.75

Translation of Nutritional Genomics into Nutrition Practice: The Next Step. Nutrients (2017) 0.75

Non-alcoholic fatty liver and the gut microbiota. Mol Metab (2016) 0.75

Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives. Adv Nutr (2017) 0.75

Microbiome and metabolome data integration provides insight into health and disease. Transl Res (2017) 0.75

Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front Microbiol (2017) 0.75

Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci U S A (2017) 0.75

Carpe diet. Nat Rev Microbiol (2017) 0.75

Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy. Front Cardiovasc Med (2017) 0.75

Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb Ecol Health Dis (2017) 0.75

A clinician's guide to microbiome analysis. Nat Rev Gastroenterol Hepatol (2017) 0.75

The path towards microbiome-based metabolite treatment. Nat Microbiol (2017) 0.75

Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct. Am J Clin Nutr (2017) 0.75

The Metabolic Response to Stress and Infection in Critically Ill Children: The Opportunity of an Individualized Approach. Nutrients (2017) 0.75

Towards an Integrative Understanding of Diet-Host-Gut Microbiome Interactions. Front Immunol (2017) 0.75

Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population. Sci Rep (2017) 0.75

The hundred most-cited publications in microbiota of diabetes research: A bibliometric analysis. Medicine (Baltimore) (2017) 0.75

Lifestyle precision medicine: the next generation in type 2 diabetes prevention? BMC Med (2017) 0.75

Atherosclerosis: Association between the gut microbiome and atherosclerosis. Nat Rev Cardiol (2017) 0.75

Reply to TMS Wolever. Am J Clin Nutr (2017) 0.75